Citation Impact
Citing Papers
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Doxorubicin pathways
2010 Standout
The management of respiratory motion in radiation oncology report of AAPM Task Group 76a)
2006 Standout
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
Cell death induced by topoisomerase-targeted drugs: more questions than answers
1998
Anthracycline and anthraquinone anticancer agents: Current status and recent developments
1993
Hallmarks of aging: An expanding universe
2023 Standout
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
1999 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Anthrazykline in der Krebstherapie
1997 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Anthracycline Antibiotics in Cancer Therapy
1994
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
The biochemistry and medical significance of the flavonoids
2002 Standout
Role of hesperetin (a natural flavonoid) and its analogue on apoptosis in HT-29 human colon adenocarcinoma cell line – A comparative study
2011
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
1993 Standout
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
1991 Standout
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Epirubicin
1993
Superspreading and the effect of individual variation on disease emergence
2005 StandoutNature
An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis
2004
Frailty: implications for clinical practice and public health
2019 Standout
Resistance of p53 knockout cells to doxorubicin is related to reduced formation of DNA strand breaks rather than impaired apoptotic signaling
2002
Inhibition of DNA Unwinding and ATPase Activities of Human DNA Helicase II by Chemotherapeutic Agents
1997
DNA methylation-based biomarkers and the epigenetic clock theory of ageing
2018 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
Combination of doxorubicin and low-intensity ultrasound causes a synergistic enhancement in cell killing and an additive enhancement in apoptosis induction in human lymphoma U937 cells
2007
Tomatidine enhances lifespan and healthspan in C. elegans through mitophagy induction via the SKN-1/Nrf2 pathway
2017
Identification and hydropathic characterization of structural features affecting sequence specificity for doxorubicin intercalation into DNA double-stranded polynucleotides
1998
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Epigenetic Aging and Immune Senescence in Women With Insomnia Symptoms: Findings From the Women’s Health Initiative Study
2016
Age-associated vulval integrity is an important marker of nematode healthspan
2016
Anthracycline Antibiotic Blockade of SV40 T Antigen Helicase Action
1998
Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications
2015 StandoutNobel
DNA methylation GrimAge strongly predicts lifespan and healthspan
2019 Standout
Epidemic Mycoplasma Pneumonia
1971
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
Natural Product Synthesis Using Multicomponent Reaction Strategies
2009 Standout
Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer.
1985
Endoplasmic reticulum-associated SKN-1A/Nrf1 mediates a cytoplasmic unfolded protein response and promotes longevity
2019 StandoutNobel
Wound Microbiology and Associated Approaches to Wound Management
2001 Standout
Short‐term interleukin‐37 treatment improves vascular endothelial function, endurance exercise capacity, and whole‐body glucose metabolism in old mice
2019
A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the radiation therapy oncology group
1980
Mycoplasma Infections of Man
1965
ANTIMYCOPLASMA ACTIVITIES OF MACROLIDE ANTIBIOTICS
1972 StandoutNobel
Aging and the Burden of Multimorbidity: Associations With Inflammatory and Anabolic Hormonal Biomarkers
2014
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Adriamycin-irradiation cutaneous complications
1977
An epigenetic biomarker of aging for lifespan and healthspan
2018 Standout
Flavonoids in Cancer and Apoptosis
2018 Standout
The Anthracycline Antineoplastic Drugs
1981 Standout
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Impact of early personal‐history characteristics on the Pace of Aging: implications for clinical trials of therapies to slow aging and extend healthspan
2017
Disruption of a topoisomerase-DNA cleavage complex by a DNA helicase.
1994
The aerobic and anaerobic bacteriology of perirectal abscesses
1997
Mycoplasma Species of Man
1965
Works of R Johnson being referenced
Helicase inhibition by anthracycline anticancer agents.
1992
Advances in Geroscience: Impact on Healthspan and Chronic Disease
2014
SMALL-CELL CARCINOMA OF THE LUNG: ATTEMPT TO REMEDY CAUSES OF PAST THERAPEUTIC FAILURE
1976
Role of Eaton Agent in Disease of Lower Respiratory Tract
1960
ANORECTAL DISEASE IN PATIENTS WITH NON-HÆMATOLOGICAL MALIGNANCY
1976